Grape King Bio Ltd is a biotechnology company that develops health foods, energy drinks, and leisure beverages for all age groups. The company operates an OEM/ODM platform offering diverse dosage forms and professional consultation services. Its product portfolio includes the Kangbeit (康貝特) series, PowerBOMB, Grape King Kombucha, and probiotic supplements featuring the proprietary GKM3 strain. The firm also produces functional ingredients such as Hericium erinaceus mycelium powder, Cordyceps cicadae, and fungal protein products. Grape King Bio Ltd serves the consumer health market in Taiwan, partnering with brands like LAIMO for limited-edition products. The company holds patents in probiotics, Hericium erinaceus, and Cordyceps technologies, and operates the Grape King Biotechnology Research Institute.

Summarised from the company's own disclosures

Industry Packaged Foods Homepage grapeking.com.tw
Sector Consumer Defensive IR page grapeking.com.tw
Tags
health foods, energy drinks, kombucha, probiotics, functional ingredients, oem/odm, fungal protein, hericium erinaceus, cordyceps, Kangbeit, PowerBOMB, Grape King Kombucha, GKM3, GKLC1, GKBio Cordyceps Cicadae, Grape King Biotechnology Research Institute
Press page —

Metrics

Valuation  
Market cap NT$ 11.11B
Market cap (USD) $ 337.219M
P/E 10.45
PEG —
P/BV 1.06
P/S 1.13
P/OCF 5.92
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 11.9%
ROI 11.8%
ROIC 16.8%
Profit margin 11.9%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -5.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 25.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 10.252B 11.16B 10.635B 10.391B 9.798B 9.168B 9.239B 9.183B 9.388B 9.185B 7.248B 6.283B 5.652B 4.612B 3.771B 3.282B
Net profit 1.218B 1.448B 1.453B 1.457B 1.3B 1.272B 1.309B 1.295B 1.352B 1.297B 1.052B 942.483M 835.762M 618.902M 473.062M 427.7M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 126.5 149.5 156 168 160 177.5 — — — — — — — — — —
Price performance 12m -0.15 -0.04 -0.07 0.05 -0.1 — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Grape King Bio Ltd (ticker 1707.TW), listed in Taiwan.

ETFs Holding Grape King Bio Ltd

ETF Weight in ETF Shares Market value As of
AVEE 0.02% 10,000 $ 23.726K Nov 16, 2026
DFEM 0.00% 159,000 $ 380.024K Nov 12, 2026
DFSE 0.00% 9,000 $ 21.511K Nov 12, 2026
DFAE 0.00% 52,000 $ 124.285K Nov 12, 2026
DFAX 0.00% 44,000 $ 105.164K Nov 12, 2026
AVEM 0.00% 143,000 $ 339.277K Nov 16, 2026
AVES 0.00% 11,000 $ 26.098K Nov 16, 2026
AVSE 0.00% 4,000 $ 9,490.28 Nov 16, 2026
AVXC 0.00% 7,000 $ 16.608K Nov 16, 2026